New eye drop aims to soothe dry eyes Long-Term
NCT ID NCT07659626
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether acoltremon eye drops can improve symptoms and tear production in people with dry eye disease over 12 months. Sixty adults will be randomly assigned to receive either the active drug or a standard artificial tear. Researchers will track changes in eye discomfort and tear levels at regular visits.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- acoltremon ophthalmic solution 0.003%
- What this could lead to
- If it works, this could point toward a new treatment option for dry eye disease that improves symptoms and tear production.
- What could go wrong
- This is a small, early-stage study with only 60 participants, so results may not apply to everyone. The control is a standard artificial tear, and the drug may not show significant benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Butchertown Clinical Trials
Louisville, Kentucky, 40206, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can insulin eye drops quench dry eyes?
- Can a new eye drop soothe severe dry eye?
- New imaging tools put to the test for measuring dry eye treatment effects
- Could a special screen light reduce tired eyes and dryness?
- Nasal spray could make contact lenses more comfortable
- Dry eye drops may sharpen cataract surgery outcomes